Antibody responses and viral load in patients with Crimean-Congo hemorrhagic fever: A comprehensive analysis during the early stages of the infection

Diagnostic Microbiology and Infectious Disease

Volumn 79, Issue 1, 2014, Pages 31-36

  Ergunay, Koray ^a   Kocak Tufan, Zeliha ^b   Bulut, Cemal ^c   Kinikli, Sami ^c   Demiroz, Ali Pekcan ^c   Ozkul, Aykut ^d  

^a HACETTEPE UNIVERSITY   (Turkey)

^b YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

^c ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d ANKARA UNIVERSITY   (Turkey)

Author keywords

Antibody; CCHF; Crimean Congo hemorrhagic fever; Immune response; Viral load

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; DISEASE DURATION; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROLOGY; TICK BITE; VIRAL CLEARANCE; VIRUS DETECTION; VIRUS LOAD; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; BLOOD; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; NAIROVIRUS; VIROLOGY;

ANTIBODIES, VIRAL; FEMALE; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MALE; VIRAL LOAD;

EID: 84898451549     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.12.015     Document Type: Article

References (30)

1. Akinci E., Bodur H., Leblebicioglu H. Pathogenesis of Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis 2013, 13:429-437.
2. Besselaar T.G., Blackburn N.K. Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies. Arch Virol 1991, 121:111-124.
3. Bodur H., Akinci E., Ascioglu S., Öngürü P., Uyar Y. Subclinical infections with Crimean-Congo hemorrhagic fever virus Turkey. Emerg Infect Dis 2012, 18:640-642.
4. Cevik M.A., Erbay A., Bodur H., Eren S.S., Akinci E., Sener K., et al. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis 2007, 45:E96-E100.
5. Deyde V.M., Khristova M.L., Rollin P.E., Ksiazek T.G., Nichol S.T. Crimean-Congo hemorrhagic fever virus genomics and global diversity. J Virol 2006, 80:8834-8842.
6. Di Bonito P., Bosco S., Mochi S., Accardi L., Ciufolini M.G., Nicoletti L., et al. Human antibody response to Toscana virus glycoproteins expressed by recombinant baculovirus. J Med Virol 2002, 68:615-619.
7. Dowall S.D., Richards K.S., Graham V.A., Chamberlain J., Hewson R. Development of an indirect ELISA method for the parallel measurement of IgG and IgM antibodies against Crimean-Congo haemorrhagic fever (CCHF) virus using recombinant nucleoprotein as antigen. J Virol Methods 2012, 179:335-341.
8. Drosten C., Kümmerer B.M., Schmitz H., Günther S. Molecular diagnostics of viral hemorrhagic fevers. Antiviral Res 2003, 57:61-87.
9. Duh D., Saksida A., Petrovec M., Ahmeti S., Dedushaj I., Panning M., et al. Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg Infect Dis 2007, 13:1769-1772.
10. Emmerich P., Avsic-Zupanc T., Chinikar S., Saksida A., Thome-Bolduan C., Parczany-Hartmann A., et al. Early serodiagnosis of acute human Crimean-Congo hemorrhagic fever virus infections by novel capture assays. J Clin Virol 2010, 48:294-295.
11. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006, 6:203-214.
12. Ergonul O. Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries. Curr Opin Virol 2012, 2:215-220.
13. Ergunay K., Whitehouse C.A., Ozkul A. Current status of human arboviral diseases in Turkey. Vector Borne Zoonotic Dis 2011, 11:731-741.
14. Jamil B., Hasan R.S., Sarwari A.R., Burton J., Hewson R., Clegg C. Crimean-Congo hemorrhagic fever: experience at a tertiary care hospital in Karachi Pakistan. Trans R Soc Trop Med Hyg 2005, 99:577-584.
15. Kalaycioglu A.T., Durmaz R., Uyar Y., Unaldi O., Aksekili E., Ozkul A., et al. Lack of genetic diversity in Crimean-Congo hemorrhagic fever viruses in Turkey: assessment of present and future patterns of disease. J Med Virol 2012, 84:471-478.
16. Karti S.S., Odabasi Z., Korten V., Yilmaz M., Sonmez M., Caylan R., et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis 2004, 10:1379-1384.
17. Maltezou H.C., Andonova L., Andraghetti R., Bouloy M., Ergonul O., Jongejan F., et al. Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness. Euro Surveill 2010, 15:19504.
18. Mardani M., Keshtkar-Jahromi M., Ataie B., Adibi P. Crimean-Congo hemorrhagic fever virus as a nosocomial pathogen in Iran. Am J Trop Med Hyg 2009, 81:675-678.
19. Midilli K., Gargili A., Ergonul O., Elevli M., Ergin S., Turan N., et al. The first clinical case due to AP92 like strain of Crimean-Congo hemorrhagic fever virus and a field survey. BMC Infect Dis 2009, 9:90.
20. Plyusnin A., Beaty B.J., Elliott R.M., Goldbach R., Kormelink R., Lundkvist A., et al. Bunyaviridae. Virus taxonomy: classification and nomenclature of viruses. Ninth Report of the International Committee on Taxonomy of Viruses 2011, 693-709. Elsevier, San Diego. A.M.Q. King, E. Lefkowitz, M.J. Adams, E.B. Carstens (Eds.).
21. Ozkaya E., Dincer E., Carhan A., Uyar Y., Ertek M., Whitehouse C.A., et al. Molecular epidemiology of Crimean-Congo haemorrhagic fever virus in Turkey: occurrence of local topotype. Virus Res 2010, 149:64-70.
22. Rodriguez L.L., Maupin G.O., Ksiazek T.G., Rollin P.E., Khan A.S., Schwarz T.F., et al. Molecular investigation of a multisource outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates. Am J Trop Med Hyg 1997, 57:512-518.
23. Saijo M., Qing T., Niikura M., Maeda A., Ikegami T., Sakai K., et al. Immunofl uorescence technique using HeLa cells expressing recombinant nucleoprotein for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus. J Clin Microbiol 2002, 40:372-375.
24. Saijo M., Tang Q., Shimayi B., Han L., Zhang Y., Asiguma M., et al. Recombinant nucleoprotein-based serological diagnosis of Crimean-Congo hemorrhagic fever virus infections. J Med Virol 2005, 75:295-299.
25. Shepherd A.J., Swanepoel R., Leman P.A. Antibody response in Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989, 11:S801-S806.
26. Tang Q., Saijo M., Zhang Y., Asiguma M., Tianshu D., Han L., et al. A patient with Crimean-Congo hemorrhagic fever serologically diagnosed by recombinant nucleoprotein-based antibody detection systems. Clin Diagn Lab Immunol 2003, 10:489-491.
27. Vanhomwegen J., Alves M.J., Zupanc T.A., Bino S., Chinikar S., Karlberg H., et al. Diagnostic assays for Crimean-Congo hemorrhagic fever. Emerg Infect Dis 2012, 18:1958-1965.
28. van Eeden P.J., van Eeden S.F., Joubert J.R., King J.B., van de Wal B.W., Michell W.L. A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital Part II. Management of patients. S Afr Med J 1985, 68:718-721.
29. Whitehouse C.A. Crimean-Congo hemorrhagic fever. Antiviral Res 2004, 64:145-160.
30. Yapar M., Aydogan H., Pahsa A., Besirbellioglu B.A., Bodur H., Basustaoglu A.C., et al. Rapid and quantitative detection of Crimean-Congo hemorrhagic fever virus by one-step real-time reverse transcriptase-PCR. Jpn J Infect Dis 2005, 58:358-362.